A1C Testing in Fort Worth, TX at DFWPMA

Looking for A1C testing in Fort Worth? At DFW Physicians Medical Associates (DFWPMA), our primary care, internal medicine, and endocrinology providers offer diabetes screening evaluations, blood sugar monitoring, and personalized diabetes care to help patients identify elevated blood glucose levels and manage their long-term health.

An A1C test, also called a hemoglobin A1C or HbA1c test, measures average blood glucose levels over approximately two to three months. This blood test helps identify prediabetes and diabetes and monitors blood sugar control in patients already diagnosed with diabetes.

Whether you’re scheduling your first diabetes screening, monitoring previously elevated blood sugar, or managing Type 1 or Type 2 diabetes, DFWPMA offers individualized medical care to help determine appropriate testing and follow-up based on your health history, risk factors, and treatment goals.

Book an appointment online or call (903) 957-0082 to contact our Fort Worth scheduling team and confirm Pap smear availability.
Address: 📍 1220 W. Presidio St., Fort Worth, TX 76102
Click here to get directions

We accept many major insurance plans. Not sure if your plan is accepted?

Call (903) 957-0082 and our team can help verify coverage.

Why Choose DFWPMA for A1C Testing in Fort Worth?

DFW Physicians Medical Associates provides diabetes screening evaluations and chronic disease management in Fort Worth through experienced family medicine, internal medicine, and endocrinology physicians who specialize in preventive healthcare, blood sugar management, and individualized treatment planning.

Patients seeking A1C testing at DFWPMA can benefit from:

  • Experienced Diabetes Care Providers: Access to Dr. Gitana Staskus, Dr. Soheila Hesami, and family medicine physicians experienced in diabetes screening, treatment, and long-term medical management.
  • Individualized A1C Screening: Assessment of age, family history, weight-related risks, previous blood sugar results, and medical conditions to determine appropriate diabetes testing recommendations.
  • Prediabetes and Diabetes Evaluation: Medical interpretation of A1C results to identify possible prediabetes, diabetes, or the need for additional diagnostic testing.
  • Specialized Endocrinology Care: Access to a board-certified endocrinologist experienced in Type 1, Type 2, gestational, and complex diabetes management.
  • Ongoing Blood Sugar Monitoring: Follow-up evaluations to assess diabetes management, medication effectiveness, and progress toward individualized blood glucose goals.
  • Patient Education and Communication: Clear explanations of A1C results, diabetes risk factors, treatment recommendations, and practical steps for managing blood sugar.
  • Coordinated Diabetes Healthcare: Access to primary care, chronic disease management, and specialized endocrinology evaluations when medically appropriate.

A1C testing is most useful when results are interpreted alongside medical history, symptoms, and other relevant laboratory findings. Testing frequency and treatment decisions should reflect individual health needs rather than relying on a single A1C measurement.

Schedule an appointment with DFWPMA Fort Worth to discuss A1C testing, diabetes screening, and your long-term blood sugar management needs.

Meet Our A1C Testing and Diabetes Care Providers in Fort Worth

Dr. Gitana Staskus, MD

Dr. Gitana Staskus is a board-certified endocrinologist with more than 20 years of clinical experience diagnosing and treating diabetes, metabolic disorders, and other endocrine conditions. Her expertise includes Type 1 diabetes, Type 2 diabetes, gestational diabetes, and complex conditions such as post-transplant diabetes.

Her clinical background supports A1C monitoring, diabetes treatment planning, and evaluation of long-term blood sugar control. Dr. Staskus emphasizes patient education and collaborative decision-making, helping adults understand laboratory results, evaluate treatment options, and participate actively in managing their diabetes.

Dr. Soheila Hesami, MD

Dr. Soheila Hesami is a board-certified internal medicine physician with more than 20 years of experience providing comprehensive healthcare for adults and older adults. Her clinical expertise includes diabetes care, preventive screenings, medication management, high blood pressure, high cholesterol, and chronic disease management.

Dr. Hesami’s experience in adult primary care supports diabetes screening evaluations, A1C monitoring, and individualized treatment planning. She emphasizes lasting patient relationships and evidence-based medicine, helping patients understand their blood sugar results, address related health conditions, and make informed decisions about their long-term care.

Book an appointment online to inquire about A1C testing and diabetes care with our Fort Worth medical providers.

What Can A1C Testing in Fort Worth Help With?

A1C testing helps identify elevated average blood glucose levels, screen for prediabetes and diabetes, and monitor long-term blood sugar control in patients with established diabetes. Unlike a single blood glucose measurement, an A1C test reflects average glucose exposure over approximately two to three months.

At DFWPMA Fort Worth, A1C testing evaluations and related diabetes care may help with:

  • Prediabetes Screening: Identifying A1C levels between 5.7% and 6.4%, which indicate prediabetes and an increased risk of developing Type 2 diabetes.
  • Type 2 Diabetes Detection: Identifying A1C levels of 6.5% or higher that may indicate diabetes and generally require diagnostic confirmation when symptoms are absent.
  • Long-Term Blood Sugar Monitoring: Assessing average glucose control over approximately two to three months in patients diagnosed with diabetes.
  • Diabetes Treatment Evaluation: Determining whether existing medications, nutrition changes, physical activity, and other management strategies are supporting individualized glucose goals.
  • Elevated Blood Sugar Follow-Up: Evaluating previously abnormal glucose measurements to determine whether repeat A1C testing or additional laboratory assessment is appropriate.
  • Individualized Diabetes Care Planning: Using A1C trends alongside medical history, treatment response, and other findings to guide ongoing diabetes management.

According to the U.S. Preventive Services Task Force (USPSTF), screening for prediabetes and Type 2 diabetes is recommended for nonpregnant adults ages 35–70 who have overweight or obesity. Screening options include A1C testing, fasting plasma glucose testing, and oral glucose tolerance testing.

For most nonpregnant adults, an A1C below 5.7% is considered normal, 5.7%–6.4% indicates prediabetes, and 6.5% or higher meets a laboratory threshold for diabetes. In patients without unequivocal hyperglycemia, diabetes diagnosis requires confirmatory testing. Screening may be appropriate earlier for individuals with additional diabetes risk factors.

An A1C test does not measure immediate blood sugar fluctuations or replace daily glucose monitoring when needed. Certain conditions affecting red blood cells, including some anemias and hemoglobin variants, can make A1C results unreliable. A1C is also not the preferred diagnostic test for gestational diabetes during pregnancy.

What A1C Testing Services Are Available in Fort Worth?

A1C testing services involve measuring glycated hemoglobin through a blood sample, interpreting average blood glucose levels, and determining whether additional diabetes evaluation or follow-up is necessary. The appropriate testing approach depends on diabetes risk, previous results, medical history, and individual treatment needs.

At DFWPMA Fort Worth, diabetes screening evaluations and related medical services may include:

  • Hemoglobin A1C Testing: Laboratory measurement of glycated hemoglobin to evaluate average blood sugar levels over approximately two to three months, subject to testing availability.
  • Diabetes Risk Assessment: Review of family history, weight-related factors, previous blood glucose results, medications, and other conditions influencing diabetes risk.
  • Prediabetes Evaluation: Assessment of elevated A1C findings and recommendations for appropriate preventive interventions, lifestyle changes, and follow-up testing.
  • Diabetes Diagnostic Evaluation: Interpretation of abnormal A1C results and recommendations for repeat testing, fasting glucose measurements, or other diagnostic assessments when indicated.
  • Diabetes Management Visits: Comprehensive medical evaluations addressing blood sugar control, treatment goals, medication needs, and associated chronic health conditions.
  • Endocrinology Consultations: Specialized evaluation for patients with Type 1 diabetes, Type 2 diabetes, difficult-to-control glucose levels, or complex endocrine conditions.
  • A1C Follow-Up and Education: Guidance regarding test results, individualized glucose targets, monitoring intervals, treatment adjustments, and recommended next steps.

During an A1C test, a healthcare professional generally collects a small blood sample from a vein or, for certain testing methods, through a fingerstick. The collection usually takes only a few minutes. Fasting is generally unnecessary for A1C testing, although other ordered blood tests may require preparation.

A1C results provide an estimate of long-term blood sugar control but must be interpreted in context. Elevated results do not automatically determine which medication or treatment is necessary. Depending on the findings, additional testing, lifestyle interventions, medication adjustments, or specialized diabetes care may be recommended.

Diabetes screening and A1C monitoring should follow evidence-based recommendations and individual medical needs. Patients with established diabetes may need testing more frequently when treatment changes or glucose goals are not being met, while screening intervals for patients without diabetes depend on their risk factors and previous results.

Looking for A1C testing in Fort Worth? Contact DFWPMA to schedule a diabetes screening or management appointment, confirm A1C testing availability, and discuss your blood sugar monitoring and treatment options.